臨牀消化器内科 Vol.23 No.13(2-2)


特集名 急性肝不全と再生医療
題名 劇症肝炎の治療 (2) 劇症肝炎に対する血液浄化療法の有効性と今後の課題
発刊年月 2008年 12月
著者 遠藤 龍人 岩手医科大学内科学消化器・肝臓内科
著者 滝川 康裕 岩手医科大学内科学消化器・肝臓内科
著者 鈴木 一幸 岩手医科大学内科学消化器・肝臓内科
【 要旨 】 劇症肝炎に対する内科的治療の基本的な方針は,高度に障害された肝機能の維持,肝障害の進展阻止,全身管理および合併症予防である.劇症肝炎における血液浄化療法(人工肝補助)の目的は,著しく低下した肝機能を補うとともに,炎症性メディエーターや有害物質を除去することにより,肝が十分な再生を得るまで,または肝移植までの体内の代謝環境を維持することにある.最近の血液濾過透析の進歩は急性型の救命率向上に寄与し,亜急性型では意識覚醒に有効と思われるが,内科的救命に向けた肝再生療法の開発が急務である.
Theme Acute Liver Failure and Regenerative Medicine of the Liver
Title Efficacy and Limitations of Artificial Liver Support System for Fulminant Hepatitis
Author Ryujin Endo Division of Gastroenterology, Showa University Fujigaoka Hospital
Author Yasuhiro Takikawa Division of Gastroenterology, Showa University Fujigaoka Hospital
Author Kazuyuki Suzuki Division of Gastroenterology, Showa University Fujigaoka Hospital
[ Summary ] Fulminant hepatitis (FH) is defined as severe hepatitis caused by rapid and extensive hepatocyte destruction in patients without a previous history of liver disease. However, in relation to FH caused by the hepatitis B virus (HBV), the term FH causes difficalties, because of fulminant hepatic failure (FHF) occurring during chronic HBV infection. In Japan, there are two kinds of FHF, including FH, related to HBV. One is FH-B, caused by acute infection with HBV and the other is FHF-B, occurring during chronic HBV infection. The difference between the two types of infection is their pathogenesis and prognosis. The prognosis for FH-B, due to acute infection, is generally favorable when patients are kept alive through intensive liver support such as the one we originated. This is true except for the "hyperacute type", in which the whole liver is almost instantaneously destroyed at the onset of the disease, and accordingly considered to be the "hyper acute type". That type of patient is an absolutely indicated for liver transplantation. The prognosis for FHF-B accompanied by chronic infection is generally less favorable, unless both persistent HBV replication and enhanced host immune reactions are effectively suppressed by the combination of antiviral and immunosuppressive treatments. If the start of treatment is delayed, patients must receive liver transplants which is very difficult for these patients.
戻る